Harvey is blind, autistic, has septo-optic dysplasia, and is one of the 2,000 people in the UK with Prader-Willi syndrome, a genetic disorder. A recognised symptom of his Prader-Willi syndrome is ...

In Malaysia, PWS is classified as a rare disease, with a prevalence of one in every 15,000 people. According to the Prader-Willi Syndrome Association of Malaysia, 195 cases have been identified as ...

The United States Food and Drug Administration (US FDA) has approved VYKAT™ XR, a significant milestone as the first approved treatment for hyperphagia in Prader-Willi syndrome (PWS). This ...

The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome ...

Federal regulators are clearing a first-of-its-kind treatment for symptoms of a rare neurodevelopmental disorder that is characterized by insatiable hunger. The Food and Drug Administration approved a ...

Since 2000, when the FDA approved recombinant human growth hormone (rhGH) for those with the rare genetic disorder Prader-Willi Syndrome (PWS ... with more than 300,000 people worldwide affected.

The FDA has approved Soleno Therapeutics’ Vykat XR (diazoxide choline) extended-release tablets to treat hyperphagia in individuals aged four years and older with Prader-Willi syndrome (PWS ...

Families of people with PWS have been prisoners in ... Chief Executive Officer of the Prader-Willi Syndrome Association | USA. “Our families experience the constant and disruptive challenges ...